BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Trevi Therapeutics to Participate in Upcoming March Events

  Trevi Therapeutics, Inc today announced that senior management will attend and participate in the following events in March.

  February 28, 2024

   · 

  2 min read
• Pharm Country

  Carisma Therapeutics to Participate in TD Cowen’s 44th Annual Health Care Conference

  Carisma Therapeutics Inc. today announced that Steven Kelly , President and Chief Executive Officer, will participate in the TD Cowen 44th Annual Health Care Conference.

  February 28, 2024

   · 

  1 min read
• Drug Development

  Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)

  Palatin Technologies, Inc. today announced results for its PL9643 MELODY-1 pivotal Phase 3 clinical trial evaluating the safety and efficacy of PL9643 versus vehicle in the treatment of dry eye disease (DED).

  February 28, 2024

   · 

  7 min read
• Drug Development

  ImmPACT Bio Awarded $8 Million CIRM Grant for Phase 1b/2 Development of IMPT-514, a CD19/CD20 Bispecific CAR T-Cell Therapy for Refractory Lupus Nephritis and Systemic Lupus Erythematosus

  ImmPACT Bio Awarded $8 Million CIRM Grant for Phase 1b/2 Development of IMPT-514, a CD19/CD20 Bispecific CAR T-Cell Therapy for Refractory Lupus Nephritis and Systemic Lupus Erythematosus.

  February 28, 2024

   · 

  6 min read
• Genetown

  Mestag Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference

  Mestag Therapeutics announced that Susan Hill, PhD, Chief Executive Officer of Mestag Therapeutics, will present at the Evercore ISI 2024 Emerging Biotech Conference on Wednesday, February 28, 2024 at 4:00 p.m. ET.

  February 28, 2024

   · 

  1 min read
• Business

  aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results

  aTyr Pharma, Inc. announced that it will report fourth quarter and full year 2023 financial results and provide a corporate update after the market close on Thursday, March 14, 2024.

  February 28, 2024

   · 

  1 min read
• HPV’s Hidden Hand: New Study by Pusan National University Scientists Reveals Key Details in Head and Neck Cancer Microenvironment

  Head and neck squamous cell carcinoma is a type of cancer that affects the mucous membranes of the mouth, nose, and throat.

  February 28, 2024

   · 

  3 min read
• Business

  Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway

  Intelligent Bio Solutions Inc. today announced its partnership with Cliantha Research to perform a pharmacokinetic (PK) study forming part of the Company’s FDA 510(k) clinical study plan.

  February 28, 2024

   · 

  5 min read
• Biotech Bay

  Vistagen to Present at TD Cowen 44th Annual Health Care Conference

  Vistagen today announced that company management will present and host one-on-one meetings at the TD Cowen 44th Annual Health Care Conference in Boston, Massachusetts, March 4 to 6, 2024.

  February 28, 2024

   · 

  1 min read
• Business

  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023

  Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months and full-year ended December 31, 2023.

  February 28, 2024

   · 

  20 min read